Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,382 across all filing types
Latest filing 2014-01-10 Share Issue/Capital Cha…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references Article 223-16 of the AMF General Regulation and provides a table detailing the total number of shares and voting rights as of a specific date (December 31, 2013). This content directly relates to the structure of the share capital and voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) category, as it is a mandatory disclosure regarding the capital structure, even though it is a monthly update rather than a major change announcement. It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a dividend notice (DIV) or director dealing (DIRS).
2014-01-10 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Board/Management Information Classification · 99% confidence The document is a press release dated January 10, 2014, announcing the appointment of a new Executive Vice President, Jonathan Barnsley, to Ipsen's Executive Committee. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. It is not a financial report (like 10-K or IR), a transcript, or a dividend notice. Therefore, the appropriate classification code is MANG.
2014-01-10 French
Communicated under the obligation to provide permanent information / Other communications
Board/Management Information Classification · 100% confidence The document is a press release dated January 10, 2014, announcing the appointment of a new Executive Vice President, Jonathan Barnsley, to the Executive Committee. This type of announcement concerns changes in senior management personnel. Reviewing the definitions, the category 'Board/Management Information (Code: MANG)' specifically covers 'Announcement of changes in the company's board of directors or senior management.' The content perfectly matches this description, as it details a key executive hire.
2014-01-10 English
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 85% confidence The document is titled "Ipsen announces its corporate agenda for 2014" and provides a schedule of key future corporate events, including sales releases, results announcements, the General Shareholders' Meeting (AGM), and dividend payment dates. This type of forward-looking schedule, especially one detailing future financial reporting dates and the AGM date, is typically released as a general corporate update or announcement. Since it is not a report itself (like 10-K or IR), but an announcement about future corporate events and reporting timelines, it fits best under the general category for corporate announcements that don't fit specific financial reporting codes. Given the options, 'Report Publication Announcement' (RPA) is plausible if it were announcing the publication of a specific report, but this is a broader 'Corporate Agenda'. 'Regulatory Filings' (RNS) serves as the best fallback for general corporate news that doesn't fit the highly specific financial or governance categories. However, since it explicitly lists the date for the 'General shareholders' meeting' and future financial reporting dates, it is a communication aimed at investors about upcoming corporate actions and disclosures. Given the options, and recognizing this is a proactive communication detailing future events rather than a specific regulatory filing or a report itself, it is closest to a general corporate announcement. Since there isn't a specific 'Corporate Calendar' code, RNS (Regulatory Filings/General Announcement) is the most appropriate catch-all for this type of informational release.
2013-12-23 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is titled "Calendrier financier 2014 du Groupe Ipsen" (Ipsen Group 2014 Financial Calendar) and explicitly lists future dates for key corporate events such as revenue announcements, results releases, and the Annual General Meeting (AGM). This document is an announcement detailing the schedule of future corporate events and reporting dates, rather than the reports themselves (like 10-K or ER). Since it announces the schedule for various future reports and the AGM, it functions as a general corporate update regarding future disclosures. Given the options, this type of forward-looking schedule announcement, which is not a specific regulatory filing like a 10-K or a specific report like an ER, fits best under the general category of Regulatory Filings (RNS) or potentially a Report Publication Announcement (RPA) if it were announcing the publication of a specific report. However, since it is a calendar of multiple future events, RNS is the most appropriate general category for miscellaneous corporate announcements that don't fit elsewhere, although it is closely related to future report releases. Given the content is purely a schedule announcement, it is not the report itself. I will classify it as RNS as a general regulatory/corporate announcement.
2013-12-23 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is explicitly titled "**PRESS RELEASE**" and announces a commercial agreement (cross-promotion) between two pharmaceutical companies, Ipsen and Mayoly Spindler, effective January 2014. This type of announcement, detailing strategic business developments rather than routine financial results (like 10-K, ER, IR) or mandatory regulatory filings (like DIRS, DEF 14A), typically falls under general corporate news or regulatory announcements. Since there is no specific category for 'Partnership Announcement' or 'Business Development,' and it is a formal announcement released to the public, the most appropriate classification is the general regulatory/miscellaneous filing category, RNS (Regulatory Filings), as it serves as a catch-all for significant, non-standard corporate news releases.
2013-12-18 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.